stoxline Quote Chart Rank Option Currency Glossary
  
Monogram Orthopaedics, Inc. (MGRM)
2.44  0.13 (5.63%)    03-28 16:00
Open: 2.4
High: 2.57
Volume: 54,266
  
Pre. Close: 2.31
Low: 2.3806
Market Cap: 76(M)
Technical analysis
2024-03-28 4:52:53 PM
Short term     
Mid term     
Targets 6-month :  3.64 1-year :  4.25
Resists First :  3.11 Second :  3.64
Pivot price 2.19
Supports First :  2.13 Second :  1.52
MAs MA(5) :  2.3 MA(20) :  2.32
MA(100) :  3.03 MA(250) :  0
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  64.3 D(3) :  57.7
RSI RSI(14): 49.8
52-week High :  48.99 Low :  1.52
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MGRM ] has closed below upper band by 21.7%. Bollinger Bands are 2.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.57 - 2.58 2.58 - 2.59
Low: 2.36 - 2.37 2.37 - 2.38
Close: 2.42 - 2.44 2.44 - 2.46
Company Description

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Headline News

Thu, 28 Mar 2024
Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Update - MarketBeat

Tue, 26 Mar 2024
Monogram Orthopaedics (NASDAQ:MGRM) and Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Survey - Defense World

Tue, 26 Mar 2024
Equities Analysts Set Expectations for Monogram Orthopaedics, Inc.'s Q1 2024 Earnings (NASDAQ:MGRM) - MarketBeat

Mon, 25 Mar 2024
Monogram Orthopaedics, Inc. Forecasted to Post Q1 2024 Earnings of ($0.12) Per Share (NASDAQ:MGRM) - Defense World

Fri, 22 Mar 2024
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth? - Simply Wall St

Thu, 21 Mar 2024
Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 32 (M)
Held by Insiders 2.225e+007 (%)
Held by Institutions 38.7 (%)
Shares Short 4 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.686e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 62.1 %
Return on Equity (ttm) -71.4 %
Qtrly Rev. Growth 365000 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.52
Qtrly Earnings Growth -0.7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -14 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 5740
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android